Passa al contenuto
Merck

NF-κB-inducing kinase increases renal tubule epithelial inflammation associated with diabetes.

Experimental diabetes research (2011-08-27)
Yanhua Zhao, Srijita Banerjee, Wanda S LeJeune, Sanjeev Choudhary, Ronald G Tilton
ABSTRACT

The impact of increased NF-κB-inducing kinase (NIK), a key component of the NF-κB activation pathways, on diabetes-induced renal inflammation remains unknown. We overexpressed NIK wild type (NIKwt) or kinase-dead dominant negative mutants (NIKdn) in HK-2 cells and demonstrated that RelB and p52, but not RelA, abundance and DNA binding increased in nuclei of NIKwt but not NIKdn overexpressed cells, and this corresponded with increases in multiple proinflammatory cytokines. Since TRAF3 negatively regulates NIK expression, we silenced TRAF3 by >50%; this increased nuclear levels of p52 and RelB, and transcript levels of proinflammatory cytokines and transcription factors. In HK-2 cells and mouse primary proximal tubule epithelial cells treated with methylglyoxal-modified albumin, multiple proinflammatory cytokines and NIK were increased in association with increased nuclear RelB and p52. These observations indicate that NIK regulates proinflammatory responses of renal proximal tubular epithelial cells via mechanisms involving TRAF3 and suggest a role for NF-κB noncanonical pathway activation in modulating diabetes-induced inflammation in renal tubular epithelium.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Sigma-Aldrich
Cocktail di inibitori delle proteasi, for use with mammalian cell and tissue extracts, DMSO solution
Sigma-Aldrich
Anticorpo anti-β-actina monoclonale murino, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Anti-Actin, N-terminal antibody produced in rabbit, ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-NFκB p52 Antibody, Upstate®, from mouse
Sigma-Aldrich
MISSION® esiRNA, targeting human TRAF3